Skip to main content
. 2018 Apr 29;89(10):1016–1023. doi: 10.1136/jnnp-2017-317887

Figure 4.

Figure 4

Survival probability of hypermetabolic versus normometabolic patients with amyotrophic lateral sclerosis (ALS) relative to time of metabolic assessment. Crude Kaplan-Meier curves during the course of 30 months for the hypermetabolic and normometabolic patients. Hypermetabolic patients had significantly worse survival (log-rank p=0.02, HR 3.2, 95% CI 1.1 to 9.4).